VFY
Healthcare & BiotechCOILED$3.180
as of 2026-07-27
5d return
+12.4%
20d return
+2.6%
60d return
+44.5%
RSI 14
58.9
vs 52w high
-16.3%
vs 52w low
+174.1%
SMA 20
Above
SMA 50
Above
Price · Volume · Broker flow
Markers = announcements (red triangle = price-sensitive). Volume amber = ≥2× ADV spike. Flow bars stacked per broker group. Flow lags T+3.
Loading chart…
Announcements — last 30 days
Vitrafy secures second high-profile partnership (after Vitalant) to address critical US blood preservation infrastructure gap created by legacy technology discontinuation in 2027. Initial deployment is non-revenue-generating pilot intended to build market traction and government stakeholder support toward longer-term commercial scale across multiple blood centers.
- 2026-07-08Expiry of Voluntary Escrow Restrictions